These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18657867)

  • 1. Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-/- mouse model of neurodegeneration.
    Kyrkanides S; Miller AW; Miller JN; Tallents RH; Brouxhon SM; Olschowka ME; O'Banion MK; Olschowka JA
    J Neuroimmunol; 2008 Oct; 203(1):50-7. PubMed ID: 18657867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
    J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice.
    Niemir N; Rouvière L; Besse A; Vanier MT; Dmytrus J; Marais T; Astord S; Puech JP; Panasyuk G; Cooper JD; Barkats M; Caillaud C
    Hum Mol Genet; 2018 Mar; 27(6):954-968. PubMed ID: 29325092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
    Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
    Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in dysmyelination by the inhibition of microglial activation in a mouse model of Sandhoff disease.
    Ogawa Y; Irisa M; Sano T; Yanagi Y; Furusawa E; Saito T; Yamanaka S; Itoh K; Sakuraba H; Oishi K
    Neuroreport; 2018 Aug; 29(11):962-967. PubMed ID: 29847465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of NK and CD8
    White EJ; Trigatti BL; Igdoura SA
    J Neuroimmunol; 2017 May; 306():55-67. PubMed ID: 28385189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
    Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
    J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease.
    Ogawa Y; Sasanuma Y; Shitara S; Koshizuka A; Okada R; Sakuraba H; Oishi K
    Neurosci Res; 2020 Jun; 155():12-19. PubMed ID: 31340161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
    Baek RC; Kasperzyk JL; Platt FM; Seyfried TN
    Neurochem Int; 2008 May; 52(6):1125-33. PubMed ID: 18207611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates.
    Walia JS; Altaleb N; Bello A; Kruck C; LaFave MC; Varshney GK; Burgess SM; Chowdhury B; Hurlbut D; Hemming R; Kobinger GP; Triggs-Raine B
    Mol Ther; 2015 Mar; 23(3):414-22. PubMed ID: 25515709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of tumor necrosis factor-α ameliorates neurodegeneration in Sandhoff disease mice.
    Abo-Ouf H; Hooper AW; White EJ; Janse van Rensburg HJ; Trigatti BL; Igdoura SA
    Hum Mol Genet; 2013 Oct; 22(19):3960-75. PubMed ID: 23727835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
    Tsuji D
    Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.
    Loth MK; Choi J; McGlothan JL; Pletnikov MV; Pomper MG; Guilarte TR
    Neurobiol Dis; 2016 Jan; 85():174-186. PubMed ID: 26545928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of inducible models of Tay-Sachs and related disease.
    Sargeant TJ; Drage DJ; Wang S; Apostolakis AA; Cox TM; Cachón-González MB
    PLoS Genet; 2012 Sep; 8(9):e1002943. PubMed ID: 23028353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice.
    Ogawa Y; Sano T; Irisa M; Kodama T; Saito T; Furusawa E; Kaizu K; Yanagi Y; Tsukimura T; Togawa T; Yamanaka S; Itoh K; Sakuraba H; Oishi K
    Sci Rep; 2017 Jan; 7():40518. PubMed ID: 28084424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.
    Keilani S; Lun Y; Stevens AC; Williams HN; Sjoberg ER; Khanna R; Valenzano KJ; Checler F; Buxbaum JD; Yanagisawa K; Lockhart DJ; Wustman BA; Gandy S
    J Neurosci; 2012 Apr; 32(15):5223-36. PubMed ID: 22496568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.
    Yamaguchi A; Katsuyama K; Suzuki K; Kosaka K; Aoki I; Yamanaka S
    J Mol Med (Berl); 2003 Mar; 81(3):185-93. PubMed ID: 12682727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene.
    Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M
    J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.